about
Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitorsEndothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.T lymphocyte-endothelial cell interactions.Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.Activation of GILZ gene by photoactivated 8-methoxypsoralen: potential role of immunoregulatory dendritic cells in extracorporeal photochemotherapy.Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder.Photopheresis: Advances and Use in Systemic Sclerosis.Nonoverlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi.Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer.Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.A Discordant Cutaneous Eruption in a Neonatal Twin.IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.Genomic landscape of cutaneous T cell lymphoma.Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome.Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis.Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden and improved survival.Are there multiple cells of origin of Merkel cell carcinoma?Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.FISH Panel for Leukemic CTCL.Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib.Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendations.The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With GlioblastomaCutaneous T-cell lymphomaPityriasis rubra pilaris: the clinical context of acantholysis and other histologic featuresRapidly enlarging nodular plaque on the legGenomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg TypeHemophagocytic Lymphohistiocytosis in Cutaneous T-Cell LymphomaCelastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosisAre MicroRNAs Key to Developing Biomarkers for Cutaneous T-Cell Lymphoma?Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas
P50
Q33784436-4B9CA8CF-E4C0-4331-B2C2-A9B162FA98A5Q33930388-5543DC18-43DD-4AF7-A6E4-436969B8C52EQ35698546-C394585E-1AFB-46F8-A885-6EB8F50BB3E8Q36646352-12EF7F1D-CF31-42DE-BC02-D67BA1890AD5Q36808610-5FF735C7-0CE8-46A2-AF7D-F68A9019CDC0Q37728623-2268416C-F79F-4785-BCFF-EC5ED0D558A7Q38677720-F0A9DDE7-EB1C-4794-9842-80B92931F196Q38694060-15092B58-5D71-4246-8294-B4C0E4CCF20EQ38807643-DD50B415-F71C-482C-9CDB-08A6446BCE86Q38843246-E49E12B8-ADEF-4DF0-8792-0EB38023E1B9Q38855013-B3854602-6C77-4012-B0E5-CF0FE7CF5267Q39315144-BF3B8E0D-346C-4CA3-852D-62952C188AE8Q39926027-180F42C4-C3DC-4C3B-8EBE-997C8E06D3C7Q40824582-8F3DB66F-E857-48EA-BBE6-A9D006E98BF3Q41654263-ABE9C055-AB12-4B3B-AC7D-0CD6F85E92E0Q42027899-BC4E0668-B0A4-4AA5-8E11-9255B439D83BQ42580718-C187B1B0-8A0A-4BAE-B86E-D2F72DB71CA5Q44381508-D9CE4476-2B23-4318-9DE0-10F8044E7DFAQ47164059-28B7BAE1-297C-42EF-91C4-406297EF48A8Q47300122-1DCAA58F-868E-45C2-AF5D-5810EEBB84EBQ47555708-387CB848-A1EA-442B-9461-9FD92BB3FD6CQ47561508-4EAB7886-D308-45AE-B038-1FEDCBDEBF14Q48149767-CCDCC0A1-3778-45DD-AA21-7353A69D21BBQ50223568-A51E7903-D0E8-4B66-A6F0-3C920B312710Q50330301-1D96B5ED-3792-49B1-A5ED-3713FE34B055Q53662237-1A27DD44-D9B1-4F2B-8245-53C5A4197CD2Q54249612-BF6404DF-458D-4BFE-8D63-438E025CE24AQ64111755-F229401D-F545-4DA8-9722-74DD9770726DQ79711350-D827BB01-0344-4437-86C0-3A16F04BC72BQ82581800-E477AA36-8333-4402-9D21-F391307ED17FQ87607211-FCAD6E36-3B34-4D83-AC70-1E03FB8D2240Q88950581-140C37E2-723D-4A9C-83AF-EC3D432C0E8DQ89010546-10A502F9-CD82-471D-B17F-2CA9D2622653Q90848531-11503016-9C75-40E4-920A-586E6FC99648Q91130444-820FE2A7-F970-4795-83A8-9D5DAFAFD03FQ91891881-D7503986-C8F3-4A18-9B33-5F2E478FCACC
P50
description
researcher
@en
հետազոտող
@hy
name
Jaehyuk Choi
@ast
Jaehyuk Choi
@en
Jaehyuk Choi
@es
Jaehyuk Choi
@nl
Jaehyuk Choi
@sl
type
label
Jaehyuk Choi
@ast
Jaehyuk Choi
@en
Jaehyuk Choi
@es
Jaehyuk Choi
@nl
Jaehyuk Choi
@sl
prefLabel
Jaehyuk Choi
@ast
Jaehyuk Choi
@en
Jaehyuk Choi
@es
Jaehyuk Choi
@nl
Jaehyuk Choi
@sl
P106
P1153
55722494400
P31
P496
0000-0003-2379-2226